Moreno Evelyn V reduced its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 49.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 982 shares of the medical research company’s stock after selling 955 shares during the period. Moreno Evelyn V’s holdings in Thermo Fisher Scientific were worth $288,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Cohen Lawrence B lifted its holdings in Thermo Fisher Scientific by 2.0% during the 2nd quarter. Cohen Lawrence B now owns 10,185 shares of the medical research company’s stock worth $2,991,000 after buying an additional 195 shares during the last quarter. Private Trust Co. NA raised its stake in shares of Thermo Fisher Scientific by 66.7% during the second quarter. Private Trust Co. NA now owns 3,273 shares of the medical research company’s stock worth $961,000 after buying an additional 1,310 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of Thermo Fisher Scientific by 4.4% during the first quarter. Parallel Advisors LLC now owns 9,416 shares of the medical research company’s stock worth $2,578,000 after buying an additional 393 shares during the last quarter. Barrett Asset Management LLC raised its stake in shares of Thermo Fisher Scientific by 0.4% during the first quarter. Barrett Asset Management LLC now owns 111,500 shares of the medical research company’s stock worth $30,520,000 after buying an additional 395 shares during the last quarter. Finally, Gateway Investment Advisers LLC raised its stake in shares of Thermo Fisher Scientific by 45.5% during the second quarter. Gateway Investment Advisers LLC now owns 38,146 shares of the medical research company’s stock worth $11,203,000 after buying an additional 11,928 shares during the last quarter. Institutional investors and hedge funds own 88.21% of the company’s stock.

A number of research firms recently weighed in on TMO. BTIG Research boosted their price target on shares of Thermo Fisher Scientific to $320.00 and gave the stock a “buy” rating in a research note on Thursday, May 23rd. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 price target for the company in a research note on Wednesday, June 12th. Barclays set a $330.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Monday, July 15th. UBS Group boosted their price target on shares of Thermo Fisher Scientific from $305.00 to $320.00 and gave the stock a “buy” rating in a research note on Thursday, May 23rd. Finally, Argus boosted their price target on shares of Thermo Fisher Scientific from $285.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Thermo Fisher Scientific has an average rating of “Buy” and an average price target of $303.17.

In other news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $284.83, for a total value of $14,241,500.00. Following the completion of the transaction, the chief executive officer now owns 342,193 shares in the company, valued at $97,466,832.19. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director C Martin Harris sold 275 shares of the company’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $270.73, for a total transaction of $74,450.75. Following the completion of the transaction, the director now owns 6,433 shares of the company’s stock, valued at approximately $1,741,606.09. The disclosure for this sale can be found here. Insiders sold 52,775 shares of company stock valued at $14,986,676 in the last quarter. Corporate insiders own 0.45% of the company’s stock.

NYSE:TMO traded up $3.56 during trading hours on Thursday, hitting $273.04. The stock had a trading volume of 50,840 shares, compared to its average volume of 1,592,969. Thermo Fisher Scientific Inc. has a one year low of $208.34 and a one year high of $305.45. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.07 and a current ratio of 1.49. The stock has a market cap of $108.93 billion, a P/E ratio of 24.54, a price-to-earnings-growth ratio of 1.78 and a beta of 1.11. The firm has a 50 day moving average price of $287.70.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, July 24th. The medical research company reported $3.04 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.01 by $0.03. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The firm had revenue of $6.32 billion during the quarter, compared to the consensus estimate of $6.31 billion. During the same quarter in the prior year, the firm earned $2.75 earnings per share. The business’s quarterly revenue was up 3.9% on a year-over-year basis. As a group, sell-side analysts expect that Thermo Fisher Scientific Inc. will post 12.24 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Tuesday, September 17th will be paid a $0.19 dividend. This represents a $0.76 annualized dividend and a yield of 0.28%. The ex-dividend date is Monday, September 16th. Thermo Fisher Scientific’s payout ratio is presently 6.83%.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Story: What is a put option?

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.